Astellas Pharma Inc: all 983 studies

Page 10 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.

• A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)CompletedNCT00337558Phase 4
• A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)CompletedNCT00337090Phase 2
• A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.CompletedNCT00333112Phase 4
• LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With ChemotherapyCompletedNCT00328588Phase 2
• Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor KidneysCompletedNCT00321113Phase 3
• Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal GraftsCompletedNCT00321074Phase 3
• A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA PatientsCompletedNCT00319917Phase 4
• An Open Study for Steroid Resistant, Non-Thymectomized MG PatientsCompletedNCT00309101Phase 3
• FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) PatientsCompletedNCT00309088Phase 3
• Optimizing Prograf® Therapy in Renal Transplant PatientsCompletedNCT00297765Phase 4
• To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.CompletedNCT00296361Phase 3
• Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney TransplantationCompletedNCT00296348Phase 3
• Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.CompletedNCT00296309Phase 3
• Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant PatientsCompletedNCT00295607Phase 2
• Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.CompletedNCT00295594Phase 3
• A Two-Stage Phase 1 Dose Escalation Pharmacokinetic Study of Tarceva in Patients With Stage IIIB/IV Non-small Cell Lung Cancer Who Continue to Smoke After Failure of One or Two Prior Chemotherapy RegimensCompletedNCT00294736Phase 1
• A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293930Phase 3
• A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293917Phase 3
• A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisCompletedNCT00293891Phase 3
• Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)CompletedNCT00285259Phase 2
• A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With InsomniaCompletedNCT00283946Phase 3
• A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant RecipientsTerminatedNCT00282230Phase 2
• Study of RSD1235 to Evaluate Safety in Patients With Atrial FibrillationCompletedNCT00281554Phase 3
• A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV MelanomaCompletedNCT00281541Phase 2
• A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and NauseaCompletedNCT00272285Phase 3
• A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With ChemotherapyCompletedNCT00257478Phase 2
• Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Male Patients With Lower Urinary Tract SyndromeCompletedNCT00239317Phase 3
• Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract SyndromeCompletedNCT00239265Phase 3
• Comparison in Efficacy and Safety Between Interferon Alfacon-1 Alone and Concomitant Dosing With Ribavirin for the Treatment of Hepatitis CCompletedNCT00239252Phase 3
• A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney TransplantationCompletedNCT00189839Phase 3
• A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.CompletedNCT00189826Phase 3
• A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNCT00189813Phase 2
• A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive BladderCompletedNCT00189800Phase 3
• Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent AsthmaCompletedNCT00189787Phase 2
• Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic PatientsCompletedNCT00189774Phase 2/3
• A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT RecipientsCompletedNCT00189761Phase 2
• A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-CompletedNCT00189748Phase 2
• A Study to Evaluate FK778 in Kidney Transplant PatientsCompletedNCT00189735Phase 2
• Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent AsthmaCompletedNCT00189722Phase 2
• Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and CandidemiaCompletedNCT00189709Phase 3
• Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNCT00189696Phase 3
• Community Based Trial for AMEVIVE®CompletedNCT00168753Phase 4
• Famotidine in Subjects With Non-erosive Gastroesophageal Reflux DiseaseCompletedNCT00141960Phase 2/3
• A Pharmacokinetic Study of Erlotinib in Cancer Patients With Advanced Solid Tumors, With Adequate and Moderately Impaired Hepatic FunctionCompletedNCT00139620Phase 1
• Effect of Rapid Steroid Withdrawal on Subclinical Markers of RejectionTerminatedNCT00133172Phase 4
• Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart SurgeryCompletedNCT00125320Phase 3
• A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line TherapyCompletedNCT00116909Phase 2
• Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid TumorsCompletedNCT00116896Phase 1
• A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent AsthmaCompletedNCT00116103Phase 2
• Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial FlutterCompletedNCT00115791Phase 3
• A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic DermatitisCompletedNCT00106496Phase 4
• Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaCompletedNCT00106288Phase 3
• Study of Micafungin in Patients With Invasive Candidiasis or CandidemiaCompletedNCT00105144Phase 3
• Study of FK778 in Renal Transplant Recipients With Untreated BK NephropathyTerminatedNCT00104338Phase 2
• YM443 in Subjects With Functional DyspepsiaCompletedNCT00102310Phase 2
• A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract CancerCompletedNCT00088270Phase 2
• A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's DiseaseTerminatedNCT00087724Phase 2
• A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsCompletedNCT00085826Phase 3
• Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) CancerCompletedNCT00073502Phase 2
• A Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)CompletedNCT00073489Phase 2
• Erlotinib (Tarceva (Trademark), OSI-774) in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00072631Phase 2
• Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00072618Phase 1/2
• CP-461 in the Treatment of Patients With Advanced MelanomaTerminatedNCT00060710Phase 2
• YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate CancerTerminatedNCT00050297Phase 2
• Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICUTerminatedNCT00048750Phase 3
• YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone TherapyTerminatedNCT00048659Phase 2
• Trial of Micafungin (FK463) in Combination With Liposomal Amphotericin B (AmBisome) for AspergillosisTerminatedNCT00047827Phase 2
• Study of FK788 in Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT00047814Phase 2
• Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian CancerCompletedNCT00046800Phase 2
• Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung CancerCompletedNCT00046787Phase 2
• A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke PatientsCompletedNCT00044070Phase 2
• A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)CompletedNCT00044057Phase 2
• CP-461 for the Treatment of Crohn's DiseaseCompletedNCT00042055Phase 2
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.CompletedNCT00040183Phase 3
• OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerCompletedNCT00036647Phase 3
• Dose-Escalating and Safety Study of CP-461 in Patients With Chronic Lymphocytic LeukemiaCompletedNCT00036257Phase 1
• Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a SulfonylureaCompletedNCT00036192Phase 2
• Study of FK463 in the Treatment of Candidemia or Invasive CandidiasisCompletedNCT00036179Phase 2
• Study of FK463 for the Treatment of Invasive AspergillosisCompletedNCT00036166Phase 2
• Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid ArthritisCompletedNCT00036153Phase 3
• Study Using CP-461 to Treat Advanced Prostate CancerCompletedNCT00036075Phase 2
• Study of CP-461 in Patients With Advanced Renal Cell CancerCompletedNCT00036036Phase 2
• Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid TumorsCompletedNCT00033241Phase 1

← Astellas Pharma Inc overview and focus areas